Avantor, Inc. (NYSE:AVTR) Position Raised by American Century Companies Inc.

American Century Companies Inc. lifted its position in shares of Avantor, Inc. (NYSE:AVTR) by 2.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,641,764 shares of the company’s stock after acquiring an additional 42,868 shares during the period. American Century Companies Inc. owned 0.24% of Avantor worth $34,805,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of AVTR. Jennison Associates LLC raised its stake in Avantor by 113.0% during the 1st quarter. Jennison Associates LLC now owns 2,497,349 shares of the company’s stock valued at $63,857,000 after acquiring an additional 1,325,026 shares in the last quarter. Swedbank AB acquired a new stake in Avantor in the first quarter worth about $2,707,000. Diversify Advisory Services LLC bought a new position in Avantor in the 1st quarter valued at about $908,000. CenterBook Partners LP acquired a new position in Avantor during the 4th quarter valued at about $4,562,000. Finally, APG Asset Management US Inc. bought a new stake in shares of Avantor during the 4th quarter worth about $2,971,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.50% of the stock is currently owned by insiders.

Avantor Stock Performance

Shares of AVTR stock opened at $26.87 on Wednesday. The company has a market capitalization of $18.27 billion, a price-to-earnings ratio of 68.90, a P/E/G ratio of 2.75 and a beta of 1.32. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The stock’s fifty day simple moving average is $24.67 and its 200-day simple moving average is $24.30.

Avantor (NYSE:AVTR) last released its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. The company had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, sell-side analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Stifel Nicolaus increased their price objective on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. Wells Fargo & Company started coverage on Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price objective on the stock. Barclays raised their target price on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $31.00 target price on shares of Avantor in a report on Monday, July 29th. Finally, Robert W. Baird raised their price objective on shares of Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $27.40.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.